Why is Mankind Pharma Ltd ?
1
Flat results in Dec 25
- ROCE(HY) Lowest at 12.33%
- DEBTORS TURNOVER RATIO(HY) Lowest at 7.13 times
2
With ROCE of 11.7, it has a Expensive valuation with a 4.6 Enterprise value to Capital Employed
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -16.50%, its profits have fallen by -17.2%
3
Below par performance in long term as well as near term
- Along with generating -16.50% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Mankind Pharma for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Mankind Pharma
-16.24%
-0.64
25.54%
Sensex
8.49%
0.74
11.41%
Quality key factors
Factor
Value
Sales Growth (5y)
19.85%
EBIT Growth (5y)
14.48%
EBIT to Interest (avg)
40.81
Debt to EBITDA (avg)
1.27
Net Debt to Equity (avg)
0.34
Sales to Capital Employed (avg)
0.81
Tax Ratio
18.29%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
24.59%
ROCE (avg)
21.63%
ROE (avg)
16.64%
Valuation Key Factors 
Factor
Value
P/E Ratio
51
Industry P/E
32
Price to Book Value
5.82
EV to EBIT
39.13
EV to EBITDA
28.85
EV to Capital Employed
4.59
EV to Sales
6.96
PEG Ratio
NA
Dividend Yield
0.05%
ROCE (Latest)
11.72%
ROE (Latest)
11.44%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
Technical Movement
6What is working for the Company
OPERATING PROFIT TO INTEREST(Q)
Highest at 5.85 times
PBT LESS OI(Q)
Highest at Rs 542.84 cr.
-3What is not working for the Company
ROCE(HY)
Lowest at 12.33%
DEBTORS TURNOVER RATIO(HY)
Lowest at 7.13 times
Loading Valuation Snapshot...
Here's what is working for Mankind Pharma
Operating Profit to Interest - Quarterly
Highest at 5.85 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 542.84 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 542.84 cr has Grown at 30.3% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 416.47 CrMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Here's what is not working for Mankind Pharma
Debtors Turnover Ratio- Half Yearly
Lowest at 7.13 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio






